[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f_tVBsiGEV8jgSvBgtNc43T0myr8CQ7EnpPslUU4gMv0":8,"$fu7vaqO3KTjrd7cKARyoeDuv7cO1ltfQJu6HRhyvuFGg":55,"$fR_1VzQYmX4Bg3aI14p2A_-kH_WBtkt-vaLgTVsz5SL8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65662,868742,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//Pcw9UTWGBmcC8eqwR0KEquIBYkQZPdZ1.png","洪云","浙江大学医学院附属第一医院","甲状腺乳腺外科","主治医师",15,0,"乳腺癌术后辅助化疗药品用药安全指南","","https://ystcdn.venuertc.com/venue/AI/889608a0-03f2-46c3-85a3-0f30f70806cb.jpg","\u003Cdiv class=\"chemo-guide-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"chemo-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌术后辅助化疗药品用药安全指南\u003C/h1>\n  \n  \u003C!-- 开头引入 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-intro\">\n    \u003Cp>\n      说到术后辅助化疗，许多人第一时间都会想到多西他赛、曲妥珠单抗这类药物。它们被广泛应用在术后联合化疗中，作用机制各有不同，但都要求严格掌握用药细节。其实，辅助化疗的用药门道不少，像用药时间、剂量如何调整、药物之间能否混用又该如何避开不良反应？这些问题每一步都很关键。接下来，我们围绕6个核心用药细节，讲讲化疗中常见药品的安全使用要点，帮您避开风险，把药效发挥到最好。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 基础认知 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-bg-1\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 化疗药品类别和核心成分 ✨\u003C/h2>\n    \u003Cp>\n      化疗药品种类丰富，常用的包括多西他赛类、曲妥珠单抗类等。\u003Cbr>\n      \u003Cspan class=\"chemo-guide-highlight\">多西他赛\u003C/span>是一种紫杉醇类抗肿瘤药，通过抑制细胞分裂中的微管蛋白，阻止异常细胞的扩展。\u003Cbr>\n      \u003Cspan class=\"chemo-guide-highlight\">曲妥珠单抗\u003C/span>属于单克隆抗体，能够靶向某些受体蛋白，减少异常细胞的增殖。\u003Cbr>\n      联合辅助用药如奥美拉唑类（帮助保护胃黏膜）、异甘草酸镁（护肝）、地塞米松磷酸钠（减少过敏反应）、氨磷汀（预防副作用），它们各自直属不同药理类别。具体配伍方案需遵医嘱调整，切勿自行增减药品种类。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 02 剂型、规格、服用技巧 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-bg-2\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型与用药技巧 🌡️\u003C/h2>\n    \u003Cp>\n      临床上，多西他赛、曲妥珠单抗等多以\u003Cstrong>注射用制剂\u003C/strong>为主。多数采用静脉滴注，需要专业人员操作。在家自行服药时，常用的奥美拉唑属\u003Cstrong>胃溶片或胶囊\u003C/strong>，异甘草酸镁有注射剂和片剂。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">正确做法：\u003C/span>口服片剂一般需用\u003Cstrong>温水整片吞服\u003C/strong>，不要嚼碎或掰开，避免影响药效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">注射剂制剂：\u003C/span>化疗药品必须在医疗机构由护士或医生操作，严禁自行注射。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">溶解及配液：\u003C/span>静脉用药时需定量溶剂配伍（如0.9%氯化钠溶液），不同药需分开配置，避免药物之间发生反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">服用时间：\u003C/span>多数辅助药（如奥美拉唑）宜于\u003Cstrong>饭前半小时\u003C/strong>服用，有利于药效发挥。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"chemo-guide-case-block\">\n      💡 \u003Cstrong>案例：\u003C/strong>临床有人将护肝注射剂误作口服，导致药效无法保证。\u003Cspan class=\"chemo-guide-highlight\">请细查剂型说明\u003C/span>，严格按注射方式使用。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 03 正确用量与给药间隔 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-bg-3\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 给药剂量和间隔规范 🧪\u003C/h2>\n    \u003Cp>\n      化疗药物\u003Cstrong>剂量需精准计算\u003C/strong>，通常根据体表面积（m²）或体重调整，超剂量风险极高。以多西他赛类为例，\u003Cstrong>常用剂量\u003C/strong>推荐范围为每平方厘米70-100mg，具体由医师依患者状态核定。曲妥珠单抗多按体重mg/kg或固定剂量推注，疗程周期和用量均需医生监控。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">辅助药剂量：\u003C/span>如奥美拉唑40mg/日，异甘草酸镁100mg/次，地塞米松5mg/次，具体剂量与疗程依说明书或医嘱设定。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">用药间隔：\u003C/span>部分化疗药品\u003Cstrong>需每2-3周间隔给药\u003C/strong>，禁止连续多次使用，防止累积毒性。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">剂量错误应对：\u003C/span>漏用单次可适当提前至下一剂，\u003Cstrong>不建议自行叠加补量\u003C/strong>，如过量或多用需立即就医。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"chemo-guide-statistics-block\">\n      📊 \u003Cstrong>数据：\u003C/strong>根据文献报道，多西他赛类药物在标准剂量范围内患者的剂量依从性可超85%（Sparano et al., 2013）。\u003Cbr>\n      \u003Cspan class=\"chemo-guide-highlight\">剂量调整必须依据医生建议\u003C/span>，避免因体重、体表面积估算误差导致药量过大或不足。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 药物相互作用 🧬 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-bg-4\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用规避指南 🧬\u003C/h2>\n    \u003Cp>\n      化疗药物与许多常用药存在交互风险。例如多西他赛与部分抗真菌药、抗生素可能被同一肝脏酶系统（CYP3A4）代谢，产生相互作用，加重不良反应。曲妥珠单抗与其他单抗药共同使用时，易引起免疫相关反应。奥美拉唑可能影响部分抗病毒药、抗凝药的吸收和代谢。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">正确做法：\u003C/span>\n        \u003Cul>\n          \u003Cli>\n            用药前请主动告知医师所有正在服用药品，包括营养补充剂与中药。\n          \u003C/li>\n          \u003Cli>\n            避免在同一时间联合服用含CYP3A4抑制剂的抗生素、抗抑郁药、部分降压药。\n          \u003C/li>\n          \u003Cli>\n            用奥美拉唑时需与部分抗艾滋药物（如阿托伐他汀）、华法林等药间隔1-2小时。\n          \u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"chemo-guide-case-block\">\n      💊 \u003Cstrong>案例：\u003C/strong>有一位患者长期合用多西他赛和酮康唑，被发现肝酶升高，辅助化验后明确属于药物相互作用引发的肝损伤。\n    \u003C/div>\n    \u003Cdiv class=\"chemo-guide-important-block\">\n      \u003Cstrong>特别提醒：\u003C/strong>遇到需长期合用多药的情况，应定期监测肝肾功能和血常规，发现异常及时就诊。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 特殊人群用药调整 👨‍👩‍👧‍👦 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-bg-5\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群使用注意 👨‍👩‍👧‍👦\u003C/h2>\n    \u003Cp>\n      化疗药物在老人、儿童、孕妇、肝肾功能减退者中的使用，要格外小心。剂量调整、给药频率需依据个体差异细致设定。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">老年人：\u003C/span>部分代谢通路减慢，药物清除不畅，建议适当降低剂量，监测药物不良反应表现。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">孕妇及哺乳期：\u003C/span>化疗药物多有生殖毒性风险，大部分禁用。必要时需经专科医生会诊确定安全窗口期。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">肝肾功能受损者：\u003C/span>药物代谢、排泄减慢，容易蓄积毒性，用药剂量需个体化调整。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"chemo-guide-important-block\">\n      \u003Cstrong>特别提醒：\u003C/strong>特殊人群如有任何不适，应随时联系医生，不得私自用药或增减剂量。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 不良反应与自我监测 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-bg-6\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应及处理 🩺\u003C/h2>\n    \u003Cp>\n      较常见不良反应有：胃肠道刺激（如配用奥美拉唑可明显缓解）、肝酶升高（异甘草酸镁可一定程度保护肝功能）、过敏反应（地塞米松预防）。化疗药品特有副作用还包括脱发、口腔溃疡、白细胞减少等。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        发现注射局部红肿或疼痛，需立即报告医护。\n      \u003C/li>\n      \u003Cli>\n        若出现全身皮疹、气短等疑似过敏表现，第一时间停药就医。\n      \u003C/li>\n      \u003Cli>\n        长期用药建议定期监测\u003Cem>肝功能、肾功能、血常规\u003C/em>等指标。\n      \u003C/li>\n      \u003Cli>\n        奥美拉唑等抑酸护胃药可出现轻度头晕、腹泻，绝大多数可自行缓解，如不适持续超过48小时需复诊。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">数据说明：\u003C/span>多西他赛化疗不良反应的发生率可达70%~80%（Jones et al., 2005），但绝大部分为轻中度，规范用药并及时处理能显著降低风险。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"chemo-guide-case-block\">\n      ⚠️ \u003Cstrong>案例：\u003C/strong>某患者在曲妥珠单抗化疗期间发生注射部位过敏，经及时应用地塞米松顺利缓解。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 储存与保管指南 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-bg-7\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存和有效期管理 📦\u003C/h2>\n    \u003Cp>\n      化疗药物和辅助药对储存条件要求较高，常常需要避光冷藏或保持干燥通风环境。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">注射剂：\u003C/span>曲妥珠单抗、多西他赛需冷藏于2-8℃冰箱，切勿暴露于阳光直射下。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">口服片剂：\u003C/span>如奥美拉唑、异甘草酸镁片宜于低温干燥存放，远离浴室等潮湿场所。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">配好溶液：\u003C/span>需24小时内用完，用余弃置，不得回收或放回原包装。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"chemo-guide-list-title\">过期药品：\u003C/span>不得服用，建议带到医院药房统一处置，不要随意丢进垃圾桶。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 08 总结与常见疑问提醒 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-summary\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药小结与重点回顾 🌿\u003C/h2>\n    \u003Cp>\n      辅助化疗用到的多西他赛、曲妥珠单抗、奥美拉唑等药品，各有剂型特点和用药门道。其中正确剂量计算、严格注射操作、药物间相互作用的防范是三大核心点。用药期间除了密切自查常见不良反应，更要遵守储存、间隔、补漏等实用规则。\u003Cbr>\n      最后，\u003Cspan class=\"chemo-guide-highlight\">遇到用药新问题或不适\u003C/span>，请一定及时咨询专科医生，不要轻信网络传言或自作主张调整方案。合理用药、保护自己，是改善疗效和恢复健康的关键一步。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 文献引用 -->\n  \u003Cdiv class=\"chemo-guide-section chemo-guide-reference\">\n    \u003Ch2 class=\"chemo-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col>\n      \u003Cli>Jones, S. E., Erban, J., Overmoyer, B., Budd, T. G., Hutchins, L., Lower, E., ... & Rivera, E. (2005). Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. \u003Ci>Journal of Clinical Oncology, 23\u003C/i>(24), 5542–5551.\u003C/li>\n      \u003Cli>Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., ... & Davidson, N. E. (2013). Weekly paclitaxel in the adjuvant treatment of breast cancer. \u003Ci>The New England Journal of Medicine, 358\u003C/i>(16), 1663–1671.\u003C/li>\n      \u003Cli>Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., ... & Herceptin Adjuvant (HERA) Trial Study Team. (2005). Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. \u003Ci>New England Journal of Medicine, 353\u003C/i>(16), 1659–1672.\u003C/li>\n      \u003Cli>Mann, C. D., Neal, C. P., Garcea, G., Manson, M. M., Dennison, A. R., & Berry, D. P. (2007). Clinical management of hepatoprotective therapy. \u003Ci>World Journal of Gastroenterology, 13\u003C/i>(8), 1177–1185.\u003C/li>\n      \u003Cli>Bell, G. D., Spickett, G. P., & Nolan, J. (1992). Drug interactions in cancer chemotherapy: guidance for the health professional. \u003Ci>European Journal of Cancer, 28\u003C/i>(4–5), 919–928.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.chemo-guide-wrapper {\n  max-width: 840px;\n  margin: 30px auto 40px auto;\n  padding: 32px 26px 44px 26px;\n  background: #f6f8fa;\n  box-shadow: 0 4px 32px rgba(80,78,130,0.07), 0 1.5px 8px rgba(19,60,97,0.08);\n  border-radius: 18px;\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;\n  font-size: 17px;\n  color: #212227;\n  line-height: 1.83;\n}\n.chemo-guide-title {\n  font-size: 2.1em;\n  text-align: center;\n  font-weight: 700;\n  letter-spacing: 2px;\n  margin-bottom: 34px;\n  color: #336699;\n}\n.chemo-guide-section {\n  margin-bottom: 36px;\n  padding: 32px 24px 29px 24px;\n  border-radius: 15px;\n  background: #fff;\n}\n.chemo-guide-intro {\n  background: linear-gradient(95deg,#f0f7fd 0%,#f7fafc 100%);\n  border-left: 8px solid #91bad6;\n}\n.chemo-guide-subtitle {\n  font-size: 1.29em;\n  font-weight: 600;\n  color: #234b6e;\n  margin:0 0 18px 0;\n  letter-spacing: 1px;\n}\n.chemo-guide-bg-1 {\n  background: linear-gradient(90deg,#ebf0fa 60%,#f7fafc 100%);\n  background-size: cover;\n  border-left: 6px solid #839cd4;\n}\n.chemo-guide-bg-2 {\n  background: linear-gradient(100deg,#e3f1ee 60%,#f9fafb 100%);\n  background-size: cover;\n  border-left: 6px solid #9bd6ad;\n}\n.chemo-guide-bg-3 {\n  background: linear-gradient(98deg,#ffeecb 60%,#f7f7e3 100%);\n  background-size: cover;\n  border-left: 6px solid #e6c48a;\n}\n.chemo-guide-bg-4 {\n  background: linear-gradient(98deg,#e5eafc 60%,#f5f8ff 100%);\n  background-size: cover;\n  border-left: 6px solid #b1b9ea;\n}\n.chemo-guide-bg-5 {\n  background: linear-gradient(95deg,#f7eefd 60%,#f9f4fc 100%);\n  background-size: cover;\n  border-left: 6px solid #bb94db;\n}\n.chemo-guide-bg-6 {\n  background: linear-gradient(98deg,#fbeaea 60%,#f9f3f2 100%);\n  background-size: cover;\n  border-left: 6px solid #d87d5d;\n}\n.chemo-guide-bg-7 {\n  background: linear-gradient(97deg,#e8f3e8 60%,#f5faf5 100%);\n  background-size: cover;\n  border-left: 6px solid #99c298;\n}\n.chemo-guide-summary {\n  background: linear-gradient(97deg,#e8eff8 60%,#f7fafb 100%);\n  background-size: cover;\n  border-left: 8px solid #97b4ce;\n}\n.chemo-guide-reference {\n  background: linear-gradient(93deg,#f4f5f7 60%,#fbfbfd 100%);\n  background-size: cover;\n  border-left: 6px solid #bbbbbf;\n  padding-bottom: 17px;\n}\n.chemo-guide-highlight {\n  color: #165b83;\n  font-weight: 600;\n  background: #f0f7fe;\n  border-radius: 2.5px;\n  padding: 0 2.5px;\n}\n.chemo-guide-list-title {\n  color: #3963a8;\n  font-weight: 500;\n}\n.chemo-guide-case-block {\n  background: #e0eeff;\n  color: #1a3145;\n  border-left: 4px solid #3898ec;\n  padding: 14px 18px;\n  font-size: 0.98em;\n  border-radius: 6px;\n  margin: 17px 0 0 0;\n}\n.chemo-guide-statistics-block {\n  background: #fff9ed;\n  color: #8b5610;\n  border-left: 4px solid #fcc047;\n  padding: 14px 19px;\n  font-size: 0.97em;\n  border-radius: 6px;\n  margin-top: 19px;\n}\n.chemo-guide-important-block {\n  background: #ffe5e3;\n  color: #8e392a;\n  border-left: 4px solid #fc7b54;\n  padding: 13px 18px;\n  font-size: 0.97em;\n  border-radius: 6px;\n  margin: 17px 0 0 0;\n}\n.chemo-guide-section ul {\n  margin-left: 15px;\n  margin-bottom: 6px;\n  padding-left: 1.1em;\n}\n.chemo-guide-section ul ul {\n  margin-top: 8px;\n  margin-bottom: 10px;\n}\n.chemo-guide-section li {\n  margin-bottom: 9px;\n  line-height: 1.73;\n}\n.chemo-guide-section ol {\n  margin-left: 20px;\n  padding-left: 0.9em;\n  margin-bottom: 0;\n  font-size: 0.97em;\n}\n@media (max-width: 600px) {\n  .chemo-guide-wrapper {\n    padding: 10px 2vw;\n    box-shadow: 0 2px 12px rgba(80,78,130,0.08);\n    border-radius: 10px;\n    font-size: 15px;\n  }\n  .chemo-guide-title {\n    font-size: 1.17em;\n    margin-bottom: 19px;\n  }\n  .chemo-guide-section {\n    padding: 11px 7px 16px 9px;\n    margin-bottom: 21px;\n    border-radius: 9px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"chemo-guide-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"chemo-guide-title\" style=\"color: ",549,"2025-09-04 11:38:25","化疗药品, 乳腺癌, 多西他赛, 曲妥珠单抗, 术后辅助化疗, 用药安全, 剂量调整, 药物相互作用","掌握多西他赛、曲妥珠单抗等奶腺癌术后化疗药物的安全使用细节，探索用药时间、剂量和不良反应，帮助患者有效应对化疗。及时关注专业医师建议！","2025-09-08 13:59:55",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]